Our data demonstrated that BO administration decreased the expression of MYC and downstream glycolytic genes of GLUT1, LDHA, HK2, and PKM2 in the CRC cells, which lessened the activity of glycolysis. This evidence concerns the gene HK2 and colorectal carcinoma.